Since 2024, the popularity of enterprises submitting applications to the Hong Kong Stock Exchange for IPOs has continued to increase.
According to the latest statistics from the Hong Kong Stock Exchange**, as of February 19, a total of 14 companies submitted their returns to the Hong Kong Stock Exchange in February, the same as in January this year. Since the beginning of this year, 28 companies have submitted their statements to the Hong Kong Stock Exchange.
Judging from the companies listed in Hong Kong this year, four of the five listed companies are located in the mainland. Among them, Jingwei Tiandi, Changchang Co., Ltd., and Suteng Juchuang are 3 from the software and service industry, and Zhongshen Construction Industry is from the construction industry, and the total amount of funds raised by the 4 companies is 15HK$400 million.
More than ninety percent of the newly listed companies in Hong Kong in 2023 are from the mainland, and mainland companies have become the main force in Hong Kong IPOs.
Among the companies that submitted to the Hong Kong Stock Exchange this year, most of them were in the clothing, food, housing and transportation and biotechnology tracks. The latest Shanghai aunt submitted a prospectus to the Hong Kong Stock Exchange on February 14, intending to be listed on the main board. Previously, there have been tea Baidao, Mixue Bingcheng, and Gu Ming have submitted prospectuses to the Hong Kong Stock Exchange.
According to investment bankers, if the materials are fully prepared and meet the listing conditions, it is expected that these four new tea beverage companies will land on the Hong Kong Stock Exchange in the first half of this year.
Brokerage investment bankers said that from the perspective of the characteristics of the enterprises submitting the statement, the mainland enterprises with strong willingness to list in Hong Kong during the year mainly came from the tracks of "clothing, food, housing and transportation", artificial intelligence, and unprofitable biomedicine.
According to the data, two biopharmaceutical companies were among the companies that submitted Hong Kong IPO applications in February. Among the companies that submitted Hong Kong IPOs in January, there were 5 biopharmaceutical companies.
Wang Rongkun, chief executive officer of Hong Kong ChinaAMC**, said that from the perspective of statistical rules, it usually takes 6 to 9 months to approve and review Hong Kong stock listing applications. In the three years ended 30 June 2023, the SFC had completed the review of 389 listing applications, of which 92% required less than 60 business days.
The faster listing speed of the Hong Kong Stock Exchange has provided a faster financing channel for mainland enterprises.
The above content and data have nothing to do with the position of the interface and do not constitute investment advice. Do so at your own risk.